Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Pharmacogenetic test
Locations
3
United States
Lancaster General Hospital
Lancaster, Pennsylvania, United States
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
March 26, 2021
Primary Completion Date
December 19, 2023
Completion Date
October 9, 2024
Last Updated
June 6, 2025
NCT04674267
NCT06596694
NCT06445062
NCT01313442
NCT06511037
NCT05789485
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions